Share-based Payment Arrangement, Expense in USD of Generation Bio Co. from Q2 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Generation Bio Co. quarterly and annual Share-based Payment Arrangement, Expense history and change rate from Q2 2019 to Q3 2025.
  • Generation Bio Co. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $1,977,000, a 47% decline year-over-year.
  • Generation Bio Co. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $8,841,000, a 49% decline year-over-year.
  • Generation Bio Co. annual Share-based Payment Arrangement, Expense for 2024 was $14,609,000, a 40% decline from 2023.
  • Generation Bio Co. annual Share-based Payment Arrangement, Expense for 2023 was $24,341,000, a 0.45% decline from 2022.
  • Generation Bio Co. annual Share-based Payment Arrangement, Expense for 2022 was $24,452,000, a 37% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Generation Bio Co. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $8,841,000 $1,977,000 -$1,775,000 -47% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $10,616,000 $1,693,000 -$2,004,000 -54% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $12,620,000 $2,011,000 -$1,989,000 -50% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $14,609,000 $3,160,000 -$2,888,000 -48% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
Q3 2024 $17,497,000 $3,752,000 -$2,252,000 -38% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $19,749,000 $3,697,000 -$2,326,000 -39% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $22,075,000 $4,000,000 -$2,266,000 -36% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 $24,341,000 $6,048,000 +$201,000 +3.4% 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $24,140,000 $6,004,000 +$156,000 +2.7% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $23,984,000 $6,023,000 -$668,000 -10% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $24,652,000 $6,266,000 +$200,000 +3.3% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q4 2022 $24,452,000 $5,847,000 +$1,409,000 +32% 01 Oct 2022 31 Dec 2022 10-K 13 Mar 2025 2024 FY
Q3 2022 $23,043,000 $5,848,000 +$878,000 +18% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $22,165,000 $6,691,000 +$1,721,000 +35% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023 2023 Q2
Q1 2022 $20,444,000 $6,066,000 +$2,587,000 +74% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 $17,857,000 $4,438,000 +$1,059,000 +31% 01 Oct 2021 31 Dec 2021 10-K 06 Mar 2024 2023 FY
Q3 2021 $16,798,000 $4,970,000 +$2,809,000 +130% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $13,989,000 $4,970,000 +$3,602,000 +263% 01 Apr 2021 30 Jun 2021 10-Q 03 Nov 2022 2022 Q3
Q1 2021 $10,387,000 $3,479,000 +$1,975,000 +131% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q4 2020 $8,412,000 $3,379,000 01 Oct 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
Q3 2020 $2,161,000 +$1,081,000 +100% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $1,368,000 +$319,000 +30% 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2021 Q2
Q1 2020 $1,504,000 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021 2021 Q1
Q3 2019 $1,080,000 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
Q2 2019 $1,049,000 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020 2020 Q2

Generation Bio Co. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $14,609,000 -$9,732,000 -40% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
2023 $24,341,000 -$111,000 -0.45% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $24,452,000 +$6,595,000 +37% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2025 2024 FY
2021 $17,857,000 +$9,445,000 +112% 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2024 2023 FY
2020 $8,412,000 +$4,205,000 +100% 01 Jan 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
2019 $4,207,000 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.